Condensed Consolidated Statement of Shareholders' Investment (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Increase (Decrease) in Shareholders' Investment
Beginning balance	$ 36,905
Net earnings	1,318	$ 2,447
Other comprehensive income (loss)	12	(100)
Ending balance	37,232
Common Shares
Increase (Decrease) in Shareholders' Investment
Beginning balance	24,709	24,470
Issued under incentive stock programs	16	14
Share-based compensation	296	324
Issuance of restricted stock awards	(533)	(504)
Ending balance	24,488	24,304
Common Shares Held in Treasury
Increase (Decrease) in Shareholders' Investment
Beginning balance	(15,229)	(11,822)
Issued under incentive stock programs	242	223
Purchased	(320)	(2,127)
Ending balance	(15,307)	(13,726)
Earnings Employed in the Business
Increase (Decrease) in Shareholders' Investment
Beginning balance	35,257	31,528
Net earnings	1,318	2,447
Cash dividends declared on common shares	(890)	(826)
Effect of common and treasury share transactions	183	146
Ending balance	35,868	33,295
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Shareholders' Investment
Beginning balance	(8,051)	(8,374)
Other comprehensive income (loss)	12	(100)
Ending balance	(8,039)	(8,474)
Noncontrolling Interests in Subsidiaries
Increase (Decrease) in Shareholders' Investment
Beginning balance	219	222
Noncontrolling Interests’ share of income, business combinations, net of distributions and share repurchases	3	8
Ending balance	$ 222	$ 230